PharmaNet Development Group Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The company offers early- and late-stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III, and IV clinical development programs. With approximately 2,300 employees in 33 countries and more than 38 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development.